Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ASTRAZENECA PHARMACEUTICALS LP
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-09-30 to 2023-03-31
Current total value of award: $1107968000
Description: DOD AND HHS, IN SUPPORT OF THE NATIONAL EMERGENCY RESPONSE TO COVID-19, REQUIRES THE MANUFACTURE, DISTRIBUTION AND STORAGE OF UP TO 1M DOSES OF ASTRAZENECA PHARMACEUTICALS AZD7442, KNOWN AS EVUSHELD, TO TREAT COVID-19 IN THE GENERAL POPULATION.